Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech IPOs: The Exit Challenge As Lockups Expire
Forbes
Thursday, October 31, 2013 - 8:34am
tags:
biotech, IPOs
Ariad suspends sales of blood cancer drug Iclusig
Reuters
Thursday, October 31, 2013 - 8:33am
tags:
Iclusig, Ariad Pharmaceuticals, FDA
AstraZeneca Profit Misses Estimates as Sales Decline
Bloomberg
Thursday, October 31, 2013 - 8:30am
tags:
AstraZeneca, earnings
J&J's Janssen Must Pay $4 Million Over Topamax, Jury Says
Bloomberg
Wednesday, October 30, 2013 - 8:45pm
tags:
Topamax, JNJ
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
TheStreet.com
Wednesday, October 30, 2013 - 11:59am
tags:
Endocyte, Europe, ovarian cancer, vintafolide
AstraZeneca (AZN) Showing Signs Of Being Water-Logged And Getting Wetter
TheStreet.com
Wednesday, October 30, 2013 - 11:58am
tags:
AstraZeneca
Questcor Pharma shares sink after drugmaker updates analysts on government investigation
Yahoo/AP
Wednesday, October 30, 2013 - 10:45am
tags:
Questcor Pharmaceuticals
FDA bans suck sales out of Ranbaxy, Wockhardt
Fierce Pharma
Wednesday, October 30, 2013 - 10:38am
tags:
FDA, Ranbaxy, Wockhardt, India
Merck works toward bringing Zilmax back to U.S., Canada
Baltimore Sun, MD
Wednesday, October 30, 2013 - 10:36am
tags:
Merck, animal health, Zilmax
Neurocrine Biosciences Reports Third Quarter 2013 Results
Yahoo
Wednesday, October 30, 2013 - 10:35am
tags:
Neurocrine Biosciences
The Rise and Fall of a Revolutionary Drug
Motley Fool
Wednesday, October 30, 2013 - 10:34am
tags:
Vertex Pharmaceuticals, Incivek, hepatitis C
Janssen Faces 2nd Trial Over Drug’s Link to Birth Defects
Bloomberg
Wednesday, October 30, 2013 - 10:12am
tags:
Janssen, birth defects, Topamax
Update on Glaxo's Vaccine Portfolio
Yahoo/Zacks
Wednesday, October 30, 2013 - 10:09am
tags:
GSK, vaccines, Synflorix
Pernix Co-Promotes with Cumberland
Yahoo/Zacks
Wednesday, October 30, 2013 - 10:07am
tags:
Pernix, Cumberland, Omeclamox-Pak, H pylori
Teva Pharmaceuticals: Copaxone's Upcoming Expiration Continues To Depress Its Current Valuation
Seeking Alpha
Wednesday, October 30, 2013 - 10:05am
tags:
Teva, MS, multiple sclerosis, Copaxone
FDA Throws More Cold Water On Amarin's Hopes For Vascepa
Forbes
Wednesday, October 30, 2013 - 10:03am
tags:
FDA, Amarin, Vascepa
Teva CEO Levin to Step Down After Reported Board Feud
Bloomberg
Wednesday, October 30, 2013 - 10:02am
tags:
Teva, Jeremy Levin, Pharma CEOs
Dendreon Grasps for Bid as Main Drug Burns Cash: Real M&A
Bloomberg
Wednesday, October 30, 2013 - 9:52am
tags:
M&A, Dendreon
Arena's Belviq Refills Week 19
Seeking Alpha
Wednesday, October 30, 2013 - 9:51am
tags:
Arena Pharmaceuticals, Belviq, Eisai
Gilead Sciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Yahoo/Seeking Alpha
Wednesday, October 30, 2013 - 9:46am
tags:
Gilead Sciences, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.